• Federal Court of Appeal Holds That Prior SAP Authorization Does Not Prevent Minister from Granting Data Protection (ELOXATIN®)
  • April 27, 2012 | Author: Daniel Daniele
  • Law Firm: Norton Rose Canada LLP - Toronto Office
  • In 2007, the Minister placed sanofi’s drug Eloxatin® on the Register of innovative drugs (“Register”) under C.08.004.1(9) of the Food and Drug Regulations, C.R.C., c. 870 (the “Regulations”).